Ulrike Wagner-Utermann

Title: Ulrike Wagner-Utermann: Innovator in Cancer Research

Introduction

Ulrike Wagner-Utermann is a prominent inventor based in Heppenheim, Germany. She has made significant contributions to the field of cancer research, particularly through her innovative work in developing labeling compounds. With a total of 2 patents, her inventions are paving the way for advancements in medical imaging and treatment.

Latest Patents

Ulrike's latest patents focus on compounds that facilitate the simple synthesis of 3'-[18F]fluoro-3'-deoxythymidine. These compounds serve as labelable precursors for the synthesis of 3'-[F]fluoro-3'-deoxythymidine. The applications detail methods for the production of these compounds, which are crucial for enhancing the efficacy of cancer diagnostics and therapies.

Career Highlights

Ulrike is affiliated with the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where she continues to push the boundaries of cancer research. Her work is characterized by a commitment to innovation and excellence, contributing to the scientific community's understanding of cancer treatment.

Collaborations

Ulrike collaborates with esteemed colleagues, including Stefan Johannes Martin and Joseph Antonius Maria Eisenbarth. These partnerships enhance her research efforts and foster a collaborative environment for scientific discovery.

Conclusion

Ulrike Wagner-Utermann's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical science and improve patient outcomes.